Rapid Dose Therapeutics Corp. RDTCF
OTC PK
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 31.12% | 34.15% | 37.24% | 26.79% | 17.35% |
| Total Depreciation and Amortization | 28.98% | 73.87% | 112.69% | 22.17% | -21.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -45.44% | -46.43% | -47.66% | -22.52% | 3.94% |
| Change in Net Operating Assets | 82.09% | 16.37% | -22.09% | 117.10% | 1,080.29% |
| Cash from Operations | 136.01% | 104.32% | 62.65% | 58.63% | 64.39% |
| Capital Expenditure | 100.00% | 84.78% | 67.50% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 35,083.02% | 40,391.30% | 46,420.00% | -- | -- |
| Total Debt Issued | -712.32% | -1,631.81% | -5,382.84% | 340.14% | -72.61% |
| Total Debt Repaid | -69.38% | -42.29% | -18.70% | 64.43% | 44.77% |
| Issuance of Common Stock | -- | -- | -- | -99.05% | -77.15% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -73.52% | -- | 603.27% | 603.27% |
| Cash from Financing | -406.87% | -395.82% | -315.45% | -55.91% | -64.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 98.06% | -44.48% | 91.46% | 152.93% | 52.02% |